Medtronic plc — Revenue by Fiscal Year
14 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/1d08433f-3b95-4ca0-bd41-215d326810ae/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $36.4B | 2025-04-26 – 2026-04-24 | evidence 0001628280-26-044354 |
| FY 2024 | $33.5B | 2024-04-27 – 2025-04-25 | evidence 0001613103-25-000091 |
| FY 2023 | $32.4B | 2023-04-29 – 2024-04-26 | evidence 0001613103-24-000072 |
| FY 2022 | $31.2B | 2022-04-30 – 2023-04-28 | evidence 0001613103-23-000040 |
| FY 2021 | $31.7B | 2021-05-01 – 2022-04-29 | evidence 0001613103-22-000023 |
| FY 2020 | $30.1B | 2020-04-25 – 2021-04-30 | evidence 0001613103-21-000027 |
| FY 2019 | $28.9B | 2019-04-27 – 2020-04-24 | evidence 0001613103-20-000021 |
| FY 2018 | $30.6B | 2018-04-28 – 2019-04-26 | evidence 0001613103-19-000028 |
| FY 2017 | $30.0B | 2017-04-29 – 2018-04-27 | evidence 0001613103-19-000028 |
| FY 2016 | $29.7B | 2016-04-30 – 2017-04-28 | evidence 0001613103-19-000028 |
| FY 2015 | $28.8B | 2015-04-25 – 2016-04-29 | evidence 0001613103-16-000093 |
| FY 2014 | $20.3B | 2014-04-26 – 2015-04-24 | evidence 0001613103-15-000028 |
| FY 2013 | $17.0B | 2013-04-27 – 2014-04-25 | evidence 0001613103-15-000028 |
| FY 2012 | $16.6B | 2012-04-28 – 2013-04-26 | evidence 0001613103-15-000028 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).